抗C1q抗体与狼疮性肾炎肾脏的病理学关系

摘要

目的 探讨抗C1q抗体与狼疮性肾炎(lupus nephritis,LN)肾脏病理的关系.方法采用酶联免疫吸附法(enzyme-linked immunosorbent assay,ELISA)对46例LN患者血清抗Clq抗体滴度进行检测,分析抗Clq抗体与病理表现(Austin肾脏病理评分和Banff肾小管病变TIL评分)间的关系.结果 抗C1q抗体在LN病理活动患者中阳性率为42.9%.抗Clq抗体与Austin肾脏病理评分CI呈负相关(r=-0.315,P<0.05);与Banff肾小管病变TIL病理评分的I值、L值呈负相关(r=-0.321,P=0.046;r=-0.397,P=0.012),抗Clq抗体与肾小球硬化率呈负相关(r=-0.335,P=0.023).抗C1q抗体在各病理类型中的分布,差异无统计学意义.结论 抗C1q抗体阳性率与LN肾脏间质损伤程度有关.%Purpose To investigate the relationship between anti-Clq antibodies and renal pathology of lupus nephritis( LN ). Methods A total of 46 LN patients were enrolled in this study, and the diagnosis was proved by renal biopsy in Peking University Shenzhen Hospital from August 2008 to August 2011. Stored serum samples from patients were obtained at the date of renal biopsy. Serum titer of anti-Clq antibody was detected by enzyme-linked immunosorbent assay ( ELISA ) following the manufacturer' s instructions. Pathological parameters were used by Austin activity indices ( AI ) and chronicity indices ( CI ), TIL-score according to the Banff Classification. Results The prevalence of anti-Clq antibody in active LN patients with renal pathology was 42. 9% . Negative correlations were found between the presence of anti-Clq antibody and CI, I, L score, and glomerular sclerosis ( r =- 0. 315, P <0. 05, r =-0. 321, P < 0. 05 , r = - 0. 397, P < 0. 05, r = - 0. 335, P < 0. 05, respectively ). Conclusion The prevalence of anti-Cl q antibody is associated with the severe degree of tubulo-interstitial lesion.